ABSTRACT SUBMISSION

ORAL COMMUNICATIONS
Oral communications consist of 15-minute presentations by the authors on the contents of their abstracts, including 5-minute discussions with questions and answers. Authors are not required to present their work also as a poster.

POSTER DISCUSSION FORUMS
In poster discussion forums, authors will give 8-minute presentations on the content of their abstracts, including 3-minute discussions with questions and answers. The authors will also present posters in the poster area.

POSTER PRESENTATION AND DISPLAY
Posters related to different subjects within the scope of clinical pharmacy will be displayed during the sym¬posium from 4 to 6 November 2009 on Level -1 at the Symposium Venue.
Accepted submissions will be presented as a poster. Selected submissions considered to have especially broad appeal may be assigned to a poster discus¬sion forum or an oral communication.
If an abstract has been accepted for presentation as an oral communication, authors are not required to present their work also as a poster. Authors will be asked to be present at their poster during the coffee breaks in order to allow discussions with other participants.

POSTER & ORAL COMMUNICATION AWARDS
The ESCP will present an award for the best poster and the best oral communication presented during the Symposium. The winners will be presented during the Closing Ceremony.

Criteria for Award Winners
The jury will review the submitted abstracts according to the selection criteria for award winners. These criteria are applicable for both the ESCP Poster Award and Oral Communication Award. They are:
1. Originality and aim: valid innovative work is valued over more routine methods; new findings are valued over a confirmation of old findings, unless controversial. The aim of the work should be clear.
2. Design of a study or service: the study or serv¬ice should be described in sufficient detail to allow understanding of its purpose and general structure; the objectives and methods should be clearly defined.
3. Results: results or accomplishments should be stated concisely and should relate to the original aim and objectives. Final results and accomplishments are rated more highly than interim reports.
4. Conclusions: conclusions should address the aim and objectives and should follow logically from the results; the utility of the data and their potential role in the management of patients should be emphasised.
5. Value to clinical pharmacy: a subject is of practical significance if it stimulates discussion among clinical pharmacists. The poster or oral communication can describe a novel approach or technique in practice or develop the role of the clinical pharmacist in the care of patients.

PRESENTATION AND PUBLICATION POLICY
All accepted abstracts for presentation (oral or poster), will be published in the official programme book of the Symposium, only if at least one of the authors has registered for the symposium before the 29th of September 2009.
Accepted and presented abstracts will be published in the Journal Pharma World & Science (PWS) after the closure of the congress. If none of the authors of an accepted abstract has attended the Symposium, and/or if the poster has not been presented during the Symposium, the abstract will not be published in PWS.